-+ 0.00%
-+ 0.00%
-+ 0.00%
Dimed adjusted 2QFY26 net profit rises 39.1% to R$ 38.9 million; adjusted EBITDA climbs 26.4% to R$ 88.5 million
Share
Listen to the news
Dimed adjusted 2QFY26 net profit rises 39.1% to R$ 38.9 million; adjusted EBITDA climbs 26.4% to R$ 88.5 million
  • Dimed posted 2Q26 gross revenue of R$ 1.64 billion, up 15.7% from 2Q25.
  • Adjusted EBITDA climbed 26.4% to R$ 88.5 million, lifting adjusted EBITDA margin by 0.4 percentage point to 5.4%.
  • Adjusted net income rose 39.1% to R$ 38.9 million, increasing adjusted net margin by 0.4 percentage point to 2.4%.
  • Digital penetration reached 33.7% of retail gross revenue, up 9.3 percentage points year over year; digital sales grew 59.8%.
  • Net debt/EBITDA improved to 0.91x from 1.1x a year earlier; store count ended the quarter at 664.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dimed SA Distribuidora de Medicamentos published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending